Keros Therapeutics Inc. (KROS)

AI Score

Unlock

14.06

0.53 (3.92%)

At close: Apr 17, 2025, 3:59 PM

14.07

0.07%

After-hours: Apr 17, 2025, 07:47 PM EDT

Keros Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-187.35M	-181.57M	-168.05M	-160.3M	-152.99M	-142.47M	-126.54M	-116.3M	-104.68M	-81.9M	-78.69M	-67.05M	-58.74M	-62.48M	-54.22M	-49.35M	-45.36M	-37.44M	-28.95M	-21.05M	-12.34M	-9.59M	-6.04M	-3.18M
Depreciation & Amortization	1.23M	1.14M	1.04M	925K	815K	695K	611K	728K	674K	651K	628K	411K	378K	349K	318K	295K	278K	262K	245K	226K	208K	149K	94K	45K
Stock-Based Compensation	34.87M	33M	32.89M	31.15M	28.76M	26.18M	22.23M	19.98M	18.68M	17.23M	15.56M	13.62M	11.72M	9.95M	8.29M	6.58M	4.1M	2.59M	1.19M	60K	59K	41K	24K	11K
Other Working Capital	-7.24M	330K	-19.38M	-13.91M	-9.97M	-7.61M	-5.19M	-10.14M	-3.28M	-23.55M	-20.53M	-18.68M	-17.55M	782K	1.73M	1.75M	2.21M	-1.9M	-5.59M	-4.87M	-8.04M	-4.47M	-3.56M	-852K
Other Non-Cash Items	16.71M	16.48M	17.61M	10.05M	1.56M	1.54M	1.42M	1.28M	953K	1.54M	727K	624K	520K	-289K	349K	337K	1.82M	2.59M	3.13M	3.72M	2.79M	1.93M	1.34M	653K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26K	26K	46K	46K	20K	20K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-10.09M	6.88M	-11.04M	-7.97M	-2.65M	-6.45M	-8.84M	-8.56M	14.31M	-5.73M	3.72M	-722K	-16.07M	1.88M	-1.75M	2.86M	2.27M	-2.41M	-2.11M	-4.57M	-6.72M	-3.03M	-2.96M	-39K
Operating Cash Flow	-160.87M	-140.32M	-143.8M	-134.83M	-124.51M	-120.49M	-111.11M	-102.87M	-70.06M	-68.18M	-58.02M	-53.07M	-62.15M	-50.57M	-46.99M	-39.28M	-36.89M	-34.4M	-26.5M	-21.61M	-16M	-10.5M	-7.54M	-2.51M
Capital Expenditures	-1.93M	-2.18M	-2.35M	-2.35M	-2.46M	-2.27M	-1.9M	-2.16M	-1.24M	-1.05M	-1.02M	-961K	-1.02M	-925K	-810K	-328K	-294K	-252K	-304K	-447K	-271K	-253K	-171K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.93M	-2.18M	-2.35M	-2.35M	-2.46M	-2.27M	-1.9M	-2.16M	-1.24M	-1.05M	-1.02M	-961K	-1.02M	-925K	-810K	-328K	-294K	-252K	-304K	-447K	-271K	-253K	-171K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	11.69M	9.98M	9.38M	8.22M	3.13M	2.41M	2.22M	983K	731K	961K	900K	455K	379K	-279K	-305K	99.76M	99.51M	99.93M	99.93M	-192K	14K	10K	4K	n/a
Financial Cash Flow	391.82M	385.53M	229.87M	228.08M	178.96M	171.12M	219.42M	227.87M	120.31M	87.31M	38.76M	28.63M	28.55M	140.25M	140.22M	240.29M	296.04M	155.93M	155.93M	55.81M	14K	10K	4K	n/a
Net Cash Flow	229.02M	243.03M	83.72M	90.9M	51.98M	48.35M	106.41M	122.84M	49.01M	18.08M	-20.28M	-25.41M	-34.62M	88.75M	92.43M	200.69M	258.86M	121.28M	129.12M	33.76M	-16.25M	-10.74M	-7.71M	-2.51M
Free Cash Flow	-162.8M	-142.5M	-146.15M	-137.18M	-126.97M	-122.77M	-113.01M	-105.03M	-71.3M	-69.23M	-59.04M	-54.03M	-63.17M	-51.5M	-47.8M	-39.61M	-37.19M	-34.65M	-26.8M	-22.05M	-16.27M	-10.75M	-7.72M	-2.51M